课题基金 / 基金详情

Development and Commercialisation of Allosteric Modulators for the Treatment of Pain

Development and Commercialisation of Allosteric Modulators for the Treatment of Pain
用于治疗疼痛的变构调节剂的开发和商业化
批准号:
315080
负责人:
Ross Ruth A
金额:
$13.84万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-09-01 至 2015-09-01
关键词:

项目摘要

项目成果

Ross Ruth A的其他基金

相似基金

相关文献

中文摘要
翻译
人体内含有被称为大麻素的化合物激活的受体。这些被称为大麻素CB1 CB2受体。大麻素被称为内源性大麻素,在组织中与大麻素相互作用 调制受体
英文摘要
The body contains receptors which are activated by compounds called cannabinoids. These are called cannabinoid CB1 and CB2 receptors. Cannabinoids called endocannabinoids are produced in the tissues where they interact with cannabinoid receptors to modula
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and Characterization of Novel CB1 Allosteric Modulators
  • 批准号:
    418503
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.73万
  • 财政年份:
    2020
  • 负责人:
    Ross Ruth A
  • 依托单位:
Development and therapeutic validation of GPR55 modulators for the treatment of osteoclast-mediated disorders
  • 批准号:
    335097
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.34万
  • 财政年份:
    2015
  • 负责人:
    Ross Ruth A
  • 依托单位:
Development and Testing of Small Molecule Allosteric Modulators for the Treatment of Pain.
  • 批准号:
    268518
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.51万
  • 财政年份:
    2012
  • 负责人:
    Ross Ruth A
  • 依托单位:
海外基金